Jennifer M. Carter - Oct 28, 2021 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Director, 10%+ Owner
Signature
/s/ Paul Ginocchio, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Oct 28, 2021
Transactions value $
$350,000
Form type
4
Date filed
11/1/2021, 08:23 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Purchase $350K +87.5K +2.22% $4.00 4.02M Oct 28, 2021 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held of record by McKesson Ventures LLC ("McKesson"). The Reporting Person, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any.